Pathologic scoring shows promise for assessing lung tumor therapy response medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
A new pathologic scoring system that accurately assesses how much lung tumor is left after a patient receives presurgical cancer treatments can be used to predict survival, according to new research led by investigators at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center and the Mark Foundation Center for Advanced Genomics and Imaging at the Johns Hopkins University.
Interrogating the Complexities of the Tumor Microenvironment 3quarksdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 3quarksdaily.com Daily Mail and Mail on Sunday newspapers.
According to new research, a biomarker signature can predict how well kidney cancer patients will respond to immunotherapy before treatment even starts